表紙:スマート植込み型ポンプの市場規模、シェア、成長分析、ポンプタイプ別、用途別、エンドユーザー別、地域別 - 産業予測、2025年~2032年
市場調査レポート
商品コード
1770782

スマート植込み型ポンプの市場規模、シェア、成長分析、ポンプタイプ別、用途別、エンドユーザー別、地域別 - 産業予測、2025年~2032年

Smart Implantable Pumps Market Size, Share, and Growth Analysis, By Pump Type (Perfusion Pumps, Micro Pumps), By Application (Pain, Spasticity), By End User, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 179 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
スマート植込み型ポンプの市場規模、シェア、成長分析、ポンプタイプ別、用途別、エンドユーザー別、地域別 - 産業予測、2025年~2032年
出版日: 2025年07月08日
発行: SkyQuest
ページ情報: 英文 179 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

スマート植込み型ポンプの世界市場規模は2023年に24億米ドルと評価され、2024年の25億7,000万米ドルから2032年には44億9,000万米ドルに成長し、予測期間(2025-2032年)のCAGRは7.2%で成長する見通しです。

世界のスマート植込み型ポンプ市場は、正確かつ継続的な治療が必要な慢性疾患の罹患率の上昇により進化しています。この需要は、効果的な治療管理のための高度な制御アルゴリズムとデータ分析に焦点を当てた機器設計の技術革新を促進します。しかし、強固なサイバーセキュリティを確保し、規制の枠組みを乗り越えることは、患者データとデバイスの安全性を守る上で依然として重要です。ヘルスケアITシステムとの統合は極めて重要であり、臨床検証のためのテクノロジープロバイダーとの連携がそれを支えています。主な動向としては、快適性向上のための小型化、生体適合性の向上、臨床医が患者のケアを継続的に監視できる遠隔モニタリング機能などが挙げられます。さらに、個別化された投与と予測的メンテナンスのための人工知能の使用は、治療の提供を変革し、患者の転帰を最適化しています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次と一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 技術分析
  • ケーススタディ
  • 規制分析

スマート植込み型ポンプ市場規模:ポンプタイプ別& CAGR(2025-2032)

  • 市場概要
  • 灌流ポンプ
  • マイクロポンプ

スマート植込み型ポンプ市場規模:用途別& CAGR(2025-2032)

  • 市場概要
  • 痛み
  • 痙縮
  • 心血管系
  • その他

スマート植込み型ポンプ市場規模:エンドユーザー別& CAGR(2025-2032)

  • 市場概要
  • 病院
  • 外来手術センター
  • その他

スマート植込み型ポンプ市場規模& CAGR(2025-2032)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 最近の市場動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 企業の詳細
    • 製品ポートフォリオ分析
    • 企業のセグメント別シェア分析
    • 収益の前年比比較(2022-2024年)

主要企業プロファイル

  • Medtronic
  • Abbott
  • Cognos Therapeutics, Inc.
  • Insulet Corporation
  • Intera Oncology
  • Abbott
  • Medtronic
  • Cognos Therapeutics, Inc.
  • Flowonix Medical
  • Cognos Therapeutic
  • Baxter
  • Pfizer Inc
  • Smiths Group Plc
  • Johnson & Johnson Services

結論と提言

目次
Product Code: SQMIG35A3076

Global Smart Implantable Pumps Market size was valued at USD 2.4 billion in 2023 and is poised to grow from USD 2.57 billion in 2024 to USD 4.49 billion by 2032, growing at a CAGR of 7.2% during the forecast period (2025-2032).

The global smart implantable pumps market is evolving due to the rising incidence of chronic conditions that necessitate precise and continuous treatment. This demand fuels innovation in device design, focusing on advanced control algorithms and data analytics for effective therapy management. However, ensuring robust cybersecurity and navigating regulatory frameworks remain critical for safeguarding patient data and device safety. The integration with healthcare IT systems is vital, supported by collaborations with technology providers for clinical validation. Key trends include miniaturization for enhanced comfort, improved biocompatibility, and remote monitoring capabilities, which enable clinicians to oversee patient care continually. Additionally, the use of artificial intelligence for personalized dosing and predictive maintenance is transforming therapy delivery and optimizing patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Smart Implantable Pumps market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Smart Implantable Pumps Market Segments Analysis

Global Smart Implantable Pumps Market is segmented by Pump Type, Application, End User and region. Based on Pump Type, the market is segmented into Perfusion Pumps and Micro Pumps. Based on Application, the market is segmented into Pain, Spasticity, Cardiovascular and Others. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Smart Implantable Pumps Market

The Global Smart Implantable Pumps market is being significantly driven by the growing need for reliable and localized drug delivery, particularly in the treatment of chronic ailments like cardiovascular diseases, cancer, and pain management. These advanced pumps provide accurate and programmable dosing while minimizing systemic side effects, which not only improves therapeutic results but also boosts patient comfort over extended use. This shift towards smart implantable technology aligns with the broader trend in healthcare that emphasizes long-term, patient-focused solutions, positioning these innovative devices as essential tools for enhancing therapy effectiveness and overall patient care.

Restraints in the Global Smart Implantable Pumps Market

The Global Smart Implantable Pumps market faces significant restraints primarily due to the high development costs associated with these devices. The intricate design process, the use of specialized materials, and the need for extensive clinical validation contribute to these expenses. Additionally, the costs incurred during surgical implantation and patient monitoring require advanced infrastructure and highly trained personnel. As a result, these financial barriers deter low-budget healthcare providers from offering smart implantable pumps, limiting accessibility, particularly in lower-resource settings. This situation restricts the market's growth potential and prevents many patients from benefiting from these advanced medical technologies.

Market Trends of the Global Smart Implantable Pumps Market

The Global Smart Implantable Pumps market is witnessing a significant trend towards the integration of connectivity and remote monitoring capabilities. With advanced wireless communication systems, these devices now support remote programming, diagnostics, and performance tracking, facilitating seamless interactions between patients and healthcare providers. This shift not only reflects the ongoing digitalization of healthcare but also enhances patient management efficiency by allowing clinicians to monitor pump activities and adjust dosing schedules from afar. As a result, there is a marked reduction in patient dependence on hospital visits, fostering improved long-term outpatient care for chronic conditions that necessitate continuous drug delivery.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technology Analysis
  • Case Studies
  • Regulatory Analysis

Global Smart Implantable Pumps Market Size by Pump Type & CAGR (2025-2032)

  • Market Overview
  • Perfusion Pumps
  • Micro Pumps

Global Smart Implantable Pumps Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Pain
  • Spasticity
  • Cardiovascular
  • Others

Global Smart Implantable Pumps Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Global Smart Implantable Pumps Market Size & CAGR (2025-2032)

  • North America (Pump Type, Application, End User)
    • US
    • Canada
  • Europe (Pump Type, Application, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Pump Type, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Pump Type, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Pump Type, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Medtronic
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cognos Therapeutics, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Insulet Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Intera Oncology
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cognos Therapeutics, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Flowonix Medical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cognos Therapeutic
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer Inc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smiths Group Plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson Services
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations